UK markets close in 4 hours 38 minutes

Embla Medical hf. (0FIW.L)

LSE - LSE Delayed price. Currency in DKK
Add to watchlist
29.60+0.35 (+1.20%)
As of 05:53PM BST. Market open.
Currency in DKK

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.59
52-week change 36.83%
S&P500 52-week change 323.10%
52-week high 333.00
52-week low 30.00
50-day moving average 331.26
200-day moving average 331.25

Share statistics

Avg vol (3-month) 32.76k
Avg vol (10-day) 32.76k
Shares outstanding 5425.08M
Implied shares outstanding 6N/A
Float 8157.81M
% held by insiders 10.11%
% held by institutions 180.29%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 7.08%
Operating margin (ttm)7.60%

Management effectiveness

Return on assets (ttm)3.82%
Return on equity (ttm)8.25%

Income statement

Revenue (ttm)804.32M
Revenue per share (ttm)1.88
Quarterly revenue growth (yoy)10.30%
Gross profit (ttm)N/A
EBITDA 107.8M
Net income avi to common (ttm)56.93M
Diluted EPS (ttm)1.04
Quarterly earnings growth (yoy)-15.00%

Balance sheet

Total cash (mrq)77.36M
Total cash per share (mrq)0.18
Total debt (mrq)559.76M
Total debt/equity (mrq)76.22%
Current ratio (mrq)1.68
Book value per share (mrq)1.71

Cash flow statement

Operating cash flow (ttm)92.83M
Levered free cash flow (ttm)29.46M